| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/24/2005 | US20050066385 Using expression vector comprising nucleotide sequences coding agamous-like-42 gene sequences(AGL42) for use as tool in the regulation and/or maintenance and/or promotion of root growth and stability |
| 03/24/2005 | US20050066381 Transgenic mouse comprising modified gene sequences associated with protein kinase c expression for use as tool in identifying modulator for treatment and prevention of cardiovascular and cardiomyopathic disorders |
| 03/24/2005 | US20050066380 Perv screening method and use thereof |
| 03/24/2005 | US20050066378 Transgenic animal comprising gene which induces lymphoproliferation for use as tool in generating autoantibodies for detection and treatment of autoimmune diseases; immunotherapy |
| 03/24/2005 | US20050066375 Genetic engineered rodent comprising gene sequences coding antigenic recognition and/or cell activation of T cell polypeptide for use in treatment and prevention of infection, viral, nervous system and inflammatory diseases |
| 03/24/2005 | US20050066266 Human CCN-like growth factor |
| 03/24/2005 | US20050065333 Breast cancer-associated genes and uses thereof |
| 03/24/2005 | US20050065332 Global suppressors of p53 mutations |
| 03/24/2005 | US20050065331 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
| 03/24/2005 | US20050065328 Gastrokines and derived peptides including inhibitors |
| 03/24/2005 | US20050065326 Immunoglobulin specific to orphan nuclear receptor (TR2) for use as tool in prevention and treatment of cell proliferative disorders |
| 03/24/2005 | US20050065325 Monoclonal antibody for use as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders |
| 03/24/2005 | US20050065324 Aggrecanase for use prognostic and/or diagnostic indicator of cell proliferative disorders |
| 03/24/2005 | US20050065323 dissecting a silkworm, removing the gland without contamination from the silkworm body fluids, extracting the silk feedstock solution, crosslinking with an aldehyde; extrusion, molding or spinning; fibroin protein fibers with improved mechanical properties |
| 03/24/2005 | US20050065322 Nucleotide sequences coding novel salivary polypeptide (ZSIG63) for use in prevention and treatment of microbial infection; microbiocides; bactericides |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065320 Mutated env gene, mutated env glycoprotein and the use thereof |
| 03/24/2005 | US20050065107 Plasmids suitable for IL-2 expression |
| 03/24/2005 | US20050065105 Modulation of APPL expression |
| 03/24/2005 | US20050065102 Medicinal compositions |
| 03/24/2005 | US20050065092 Method of treating obesity and metabolic disorders related to excess adipose tissue by administration of natriuretic peptide receptor C inhibitors |
| 03/24/2005 | US20050065090 Wound healing agents; hydration; wrinkle resistance; aging resistance; radiation resistance; forming collagen, , fibronectin |
| 03/24/2005 | US20050065085 Tissue disorders in response to injuries with administering polypeptidesand antibodies with gene delivery for inflammation such as arthritis |
| 03/24/2005 | US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders |
| 03/24/2005 | US20050065083 Promoting survival of nerve cells; stimulating cell differentiation; amyotropic lateral scleerosis |
| 03/24/2005 | US20050065081 Using a protein; diagnosis, therapy cancer |
| 03/24/2005 | US20050065079 Therapy for metabolism disorders ; obesity; antilipemic agents; atherosclerosis; hypotensive agents; antidiabetic agents |
| 03/24/2005 | US20050065077 Anticarcinogenic agents |
| 03/24/2005 | US20050065076 Gamma three protease |
| 03/24/2005 | US20050065075 Viricides; respiratory synctia virus; parainfluenza virus; simian immunodeficiency virus; complexing drug to blood component; immobilization; storage stability |
| 03/24/2005 | US20050065074 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 03/24/2005 | US20050065067 tetramer-free, substantially stroma-free, polymerized, pyridoxylated hemoglobin; free of leukocytes (white blood cells) and platelets |
| 03/24/2005 | US20050065066 Stabilised insulin compositions |
| 03/24/2005 | US20050065065 Modulation of the expression of estrogen receptors for the prevention or treatment of heart disease |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064563 Nucleotide sequences coding gene cluster assoiated with biosynthesis of coumermycin for use as tool in prevention and treatment of infection and cell proliferative disorders |
| 03/24/2005 | US20050064562 fermentaion of amino acids for use in human medicine, foods and animal nutrients; fermenting modified coryneform bacterium; modifiied by reducing or eliminating the intracellular activity of MikE17 in said cell relative to the activity of MikE17 in an unmodified bacterium of the same strain |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064557 Method for producing proteins |
| 03/24/2005 | US20050064556 Transforming yeast cell with expression vector expressing gene coding tissue factor pathway inhibitor (TFPI) and tissue factor pathway inhibitor-2 (TFPI-2) for use as tool in treatment and prevention of thrombosis; bioreactors |
| 03/24/2005 | US20050064555 Ciliary neurotrophic factor variants |
| 03/24/2005 | US20050064554 Canine GHRH gene, polypeptides and methods of use |
| 03/24/2005 | US20050064553 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 03/24/2005 | US20050064549 Receptor |
| 03/24/2005 | US20050064548 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 03/24/2005 | US20050064547 Vectors and transfected cells |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064542 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/24/2005 | US20050064541 For immunoregulation and/or treatment of inflammation; muteins, |
| 03/24/2005 | US20050064533 Asparagine hydroxylation of the cad domain of a hif protein |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064527 Identifying modulator of activity of newly identified multiple antibiotic resistance (mar) locus regulated (NIMR) gene products; microbiocides; bactericides |
| 03/24/2005 | US20050064526 Immunoglobulin fusion comprising bacterial toxin for use in prevention and treatment of bacterial infection; bactericides; microbiocides; genetic vaccines |
| 03/24/2005 | US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use |
| 03/24/2005 | US20050064520 New assays for preimplantation factor and preimplantation factor peptides |
| 03/24/2005 | US20050064509 Use of templated self assembly to create novel multifunctional species |
| 03/24/2005 | US20050064504 DNA encoding the prostate-specific membrane antigen-like gene and uses thereof |
| 03/24/2005 | US20050064499 Expression vector coding nucleotide sequences for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064480 Nucleotide sequences coding formin-like 2 (FHOD-2) gene for use as diagnostic and therapeutic tool in detection and treatment of pancreatic disorders |
| 03/24/2005 | US20050064475 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 03/24/2005 | US20050064474 Cleaving cellular chromatin and inserting expression vector comprising nucleotide sequences coding zinc finger-cleavage half domain genetic exchange; genome engineering and homologous recombination |
| 03/24/2005 | US20050064467 Expression vector comprising scaffold/matrix attached region (S/MAR), an origin of replication (ORI) and one replication initiation factor for use as tool in transfer and expression of heterologous nucleotide sequences; biodrugs |
| 03/24/2005 | US20050064466 Novel human 7TM proteins and polynucleotides encoding the same |
| 03/24/2005 | US20050064464 Optimization of immunomodulatory properties of genetic vaccines |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064448 Osteoclast proton pump subunit |
| 03/24/2005 | US20050064445 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064439 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 03/24/2005 | US20050064430 Rabconnectin-3-binding protein |
| 03/24/2005 | US20050064420 Expression vector comprising nucleotide sequences coding estrogen response element for use as regulatory tool in heterologous gene expression |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064413 Oncogenic protein for use in diagnosis, prevention and treatment of cell proliferative disorders of nervous ystem |
| 03/24/2005 | US20050064411 Diagnostic probe for identifying ubiquitin ligase (NEDl-1) profile for use as diagnostic and prognostic indicator of cell proliferative disorders of nervous system |
| 03/24/2005 | US20050064405 Nucleotide sequences coding metallo beta -lactamase (VDJ protein) for use as tool in diagnosis, treatment and prognosis of cell proliferative disorders |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064401 Diagnosis of illnesses or predisposition to certain illnesses |
| 03/24/2005 | US20050064399 Nucleic acids encoding human CIDE-B protein and polymorphic markers thereof |
| 03/24/2005 | US20050064396 Cellular regulators of infectious agents and methods of use |
| 03/24/2005 | US20050064394 Viral deletion mutant comprising nucleotide sequences associated with temperance factors for use as tool in detection of modulators which prevent and treat viral infection; viricides; genetic vaccines |
| 03/24/2005 | US20050064392 Expression vector comprising nucleotide sequences coding viral envelope proteins for use as tool in developing genetic vaccines to prevent, block and/or treat viral infection/disease |
| 03/24/2005 | US20050064391 Lectin compositions and methods for modulating an immune response to an antigen |
| 03/24/2005 | US20050064390 Transgenic cell line expressing chemokine receptor for use as model in identifying modulators wich prevent/block viral infection; viricides |
| 03/24/2005 | US20050064389 Chimeric lyssavirus nucleic acids and polypeptides |
| 03/24/2005 | US20050064007 Surface-modified implants |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063989 Ion channel hybrid proteins as electrical sensors and use thereof |
| 03/24/2005 | US20050063988 Containing a hybrid fusion polypeptide that includes a multivalent immunogenic portion of at least two immunogenic polypeptides from Group A streptococci M proteins and a carboxy-terminal reiterated immunogenic polypeptide |
| 03/24/2005 | US20050063987 Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use |
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063984 Antigenic peptide fragments of vapa protein, and uses thereof |
| 03/24/2005 | US20050063983 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/24/2005 | US20050063982 GRP94-based compositions and methods of use thereof |
| 03/24/2005 | US20050063981 Expression vectors, eukaryotic and prokaryotic cell lines; cancer vaccines |